Microbial Identification Market Size, Share, Report, 2022-2028

Comments · 149 Views

The global microbial identification market size reached US$ 4.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2028, exhibiting a growth rate (CAGR) of 11.48% during 2023-2028.

Industry Overview ofMicrobial Identification Market

Microbial identification is a process used to determine the presence of microorganisms and aids in ensuring product quality, maintaining safety standards, and preventing the spread of infectious diseases. It involves traditional culture-based methods, molecular techniques, and advanced technologies like mass spectrometry and deoxyribonucleic acid (DNA) sequencing. It assists businesses in taking appropriate measures to control contamination, develop effective treatment strategies, and ensure compliance with regulatory requirements. It helps detect and classify microorganisms based on their genetic material and metabolic characteristics. It is extensively used in various industries, such as healthcare, pharmaceuticals, and food and beverages (FB). Besides this, as it provides safety, hygiene, and quality assurance, the demand for reliable and efficient microbial identification solutions is rising across the globe.

How Big Is the Microbial Identification Market?

The globalmicrobial identificationmarketsize reached US$ 4.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2028, exhibiting a growth rate (CAGR) of 11.48% during 2023-2028.

GlobalMicrobial Identification MarketTrends and Drivers:

The increasing emphasis on food safety and the prevention of foodborne illnesses are catalyzing the demand for microbial identification solutions. Additionally, the rising prevalence of hospital-acquired infections (HAIs) is escalating the need for accurate diagnosis and treatment of infectious diseases and leading to the adoption of microbial identification techniques. Moreover, the increasing utilization of microbial identification in the pharmaceutical industry to ensure the sterility of drugs and comply with regulatory standards is favoring market growth. Furthermore, rising environmental pollution and the need to monitor microbial contaminants in water, air, and soil are strengthening the market growth.

Request a free sample of report:https://www.imarcgroup.com/microbial-identification-market/requestsample

What Is Included In Market Segmentation?

The report has been segmented the market into following categories:

Breakup by Products and Services:

  • Instruments and Software
  • Consumables
    • Panels/ID Cards and Media
    • Kits
    • Others
  • Services

Breakup by Technology:

  • Mass Spectrometry
  • PCR
  • Flow Cytometry
  • Microscopy
  • Others

Breakup by Method:

  • Phenotypic Methods
  • Genotypic Methods
  • Proteomics-Based Methods

Breakup by Application:

  • Diagnostics
  • Food and Beverage Testing
  • Pharmaceuticals
  • Cosmetics and Personal Care Products Testing
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report provides a comprehensive analysis of the industry key players listed below:

Beckman Coulter Inc. (Danaher Corporation), Biolog Inc., BioMerieux SA, Bruker Corporation, Charles River Laboratories International Inc., Eurofins Scientific SE, Liofilchem S.r.l, Merck KGaA, Shimadzu Corporation, Thermo Fisher Scientific Inc., VWR International LLC. (Avantor Inc.) and Wickham Micro Limited.

Ask Analyst for 10% free customized report:https://www.imarcgroup.com/request?type=reportid=6176flag=C

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Comments